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Abstract
Abstract Because antioxidants may play a role in the prevention of coronary heart
disease by inhibiting the peroxidation of polyunsaturated fatty acids (PUFAs), the
combined association of diet-derived antioxidants and PUFAs with acute myocardial
infarction (MI) was investigated. This multicenter case-control study included 674
patients and 725 control subjects in eight European countries and Israel. Fatty acid
composition and α-tocopherol and β-carotene levels were determined in adipose
tissue; selenium level was determined in toenails. For α-tocopherol no association
with MI was observed at any PUFA level. The overall multivariate odds ratio (OR) for
low (10th percentile) versus high (90th percentile) β-carotene was 1.98 (95%
confidence interval [CI], 1.39 to 2.82). The strength of this inverse association with
MI was dependent on PUFA levels (in tertiles): for low PUFA, the OR for low versus
high β-carotene was 1.79 (95% CI, 0.98 to 3.25), for medium PUFA the OR was 1.76
(95% CI, 1.00 to 3.11), and for high PUFA 3.47 (95% CI, 1.93 to 6.24). For selenium
increased risk was observed only at the lowest PUFA tertile (OR, 2.49; 95% CI, 1.22
to 5.09). This interaction between selenium and PUFAs was not significant and may
at least partly be explained by a higher proportion of smokers at the low PUFA
level. These findings support the hypothesis that β-carotene plays a role in the
protection of PUFAs against oxidation and subsequently in the protection against
MI. No evidence was found that α-tocopherol or selenium may protect against MI at
any level of PUFA intake.
Key Words:
antioxidants
β-carotene
fatty acids
myocardial infarction
α-tocopherol
Received January 2, 1995.
Accepted March 14, 1995.
Experimental as well as epidemiological studies have accumulated evidence to
suggest that antioxidants may play a part in the prevention of cardiovascular
disease.  Micronutrients such as vitamin E, β-carotene, and selenium may protect
the LDL cholesterol particle against oxidation in the vascular subendothelium  and
thereby prevent the enhanced uptake of cholesterol by macrophages, leading to the
formation of foam cells.  In vitro studies have shown that the resistance of LDL
against oxidation is dependent not only on antioxidant levels  but also on its
fatty acid composition. Polyunsaturated fatty acids (PUFAs) are most susceptible to
oxidation. Increasing the ratio of oleic to linoleic acid in LDL by dietary intervention
reduces the uptake of the LDL by macrophages in vitro.
Several studies  have shown an inverse association of dietary antioxidant
intake or plasma or serum concentrations with risk of cardiovascular disease, but
others  have not. This lack of association may be attributed to relatively
high levels of antioxidants in these populations or to deterioration of vitamin E
during prolonged storage. It is also possible that the balance between antioxidants
and polyunsaturates is the more important factor. Kok et al  have reported lower
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selenium-to-PUFA ratios in patients with severe versus mild atherosclerosis.
Here we present the results of a case-control study on the combined association of
antioxidants and PUFAs with the risk of acute myocardial infarction (MI) in nine
different countries. Levels of antioxidants and fatty acids in plasma or lipoproteins
may be affected by recent dietary changes and by the acute event of an MI.
Therefore, concentrations of α-tocopherol, β-carotene, and fatty acids in
subcutaneous adipose tissue and selenium in toenails were compared between 674
case subjects with acute MI and 725 control subjects without a history of infarction.
Methods
Design and Subjects
Eligible subjects in this study, conducted during 1991 and 1992, were men under
70 years of age from 10 study centers in nine countries. They were native residents
of their respective countries with stable dietary and weight patterns during the
previous year, ie, no changes in the use of dietary supplements containing
α-tocopherol, β-carotene, or selenium, no new or altered dietary prescription or
advice for health reasons, and no weight loss over 5 kg. Cases were subjects
diagnosed with a first acute MI (ICD code 410) that had been confirmed by specific
abnormalities on an electrocardiogram and by elevated enzyme levels. These
subjects had been admitted within 24 hours of manifesting symptoms and were
recruited from the coronary care unit of participating hospitals. Control subjects
had no history of MI and were frequency matched for age according to 5-year
intervals. Control subjects were recruited from the population in the catchment
area, from population registers, or from other appropriate sources. In some
centers, control subjects were selected from among hospital patients with diseases
that were not known to be associated with antioxidant status (renal colic,
noninfectious prostatism, acute appendicitis, noninfectious otic pathology, hernia,
volvulus, or rectal/anal pathology [except cancer, hemorrhoids, or chronic
infections]). If low response rates from population-based samples might affect the
internal validity, control subjects were selected from the catchment area via a
random sample by the patient’s general practitioner (Netherlands) or by inviting
friends and relatives of the case (Norway). Excluded from both groups were
subjects with a history of treatment for alcohol or drug abuse, those diagnosed
with major psychiatric disorders that would interfere with their ability to give
informed consent, and institutionalized subjects. Informed consent was obtained
from all subjects, and the study protocol was approved by the appropriate
institutional committees on human experimentation. The study design has been
reported in detail.
Biochemical Analyses
Subcutaneous adipose tissue was taken from the buttock by needle aspiration.  In
case subjects, the adipose sample was taken within 7 days of hospital admission.
Samples were stored at −70°C; handling of the samples has been described.
Samples were analyzed in a central laboratory. Concentrations of α-tocopherol and
β-carotene in adipose tissue were determined by reverse-phase high-performance
liquid chromatography  and spectrophotometric detection. The coefficient of
variation for the analysis of β-carotene and α-tocopherol was 7% (at mean values
of 2.1 and 84 µg/g in the quality control samples, respectively). Detection limits
were 0.02 µg/g for β-carotene and 2 µg/g for α-tocopherol at a mean sample
weight of 29 mg. Vitamin concentration was expressed in micrograms per gram of
total fatty acids.
Fatty acids were assayed centrally at the National Public Health Institute, Helsinki,
Finland. The saponified sample was acidified with HCl, and the free fatty acids were
extracted with hexane and methylated with acidic methanol. Fatty acid composition
was determined by a gas chromatograph (HNU Nordion Oy, HRCG 412) with a
60-m-long SP-2380 column, an internal diameter of 0.32 mm, a phase layer of
0.20 µm with a split injector, and helium as carrier gas. Fatty acid peaks from
C12:0 (fatty acid with 12 carbon atoms/0 double bonds) to C22:6 were identified
by an SC workstation (Sunicom Oy) in a temperature-programmed run. PUFAs
include linoleic acid (C18:2), alpha-linolenic acid (C18:3), and arachidonic acid
(C20:4); monounsaturated fatty acids (MUFAs) are C14:1, palmitoleic acid (C16:1),
oleic acid (C18:1), and eicosaenoic acid (C20:1); saturated fatty acids (SFAs) include
lauric acid (C12:0), myristic acid (C14:0), palmitic acid (C16:0), and stearic acid
(C18:0). All fatty acids are expressed as a proportion of total fatty acids. Because
minor fatty acids are not included in these aggregated categories, proportions of
PUFAs, MUFAs, and SFAs do not add up to 100%.
Serum total cholesterol levels were determined in Helsinki by using enzymatic
methods (kits by Boehringer-Mannheim GmbH), HDL cholesterol was determined
after precipitation with dextran sulfate and magnesium chloride, and LDL
cholesterol was calculated by the Friedewald formula. In case subjects, cholesterol
concentrations were inversely related to time from onset of symptoms (Pearson
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r=−.18, P<.001), which may be due to the effect of acute MI on serum cholesterol.
Toenail clippings were collected within 8 weeks of a subject’s inclusion in the study
and were stored in small plastic bags at room temperature. Nails were cleaned
before clipping. The selenium content of the toenails was assessed by instrumental
neutron-activation analysis of the metastable selenium-77 isotope (Interfaculty
Reactor Institute, Delft University, Netherlands).  Samples were irradiated for 17
seconds in a thermal flux of 1.2×10  neutrons · s  · cm . After a decay time
of 20 seconds, gamma radiation of Se was measured for 60 seconds. Mean level
of selenium (n=87) in certified bovine liver reference material (NBS-1577A) was
0.76±0.04 ppm against a certified value of 0.80±0.04 ppm. Reproducibility of
measurement was evaluated by repeated analysis of 19 samples; the coefficient of
variation was 5%.
Data Analysis
Questionnaire data were available for 1499 eligible subjects. Vitamin results were
unavailable (no adipose tissue in adaptor) for 34 subjects (30 case and 4 control
subjects). Extreme values caused by measurement error due to very small sample
size were excluded (38 case and 28 control subjects), leaving 674 case and 725
control subjects for data analysis. Fifty-five case and 24 control subjects lacked
toenail samples; 4 case and 5 control subjects had selenium values below the
detection level and were handled as missing values as well. Of the remaining
subjects, 28 case subjects and 4 control subjects had provided no biopsy, leaving
655 case and 724 control subjects for the data analysis of selenium in combination
with fatty acid composition.
Crude means for major risk factors and potential confounders were computed; the
difference between case and control groups was tested by using Student’s t test
and χ  analysis. Mean center-adjusted levels of antioxidants and fatty acids (as a
proportion of total fatty acids) were calculated for both groups. As the distribution
of PUFAs and MUFAs was skewed, the loge-transformed values were used. Potential
confounders of the association between antioxidants and MI were identified by
using stratified analysis. Partial (center-adjusted) correlations between antioxidants
and fatty acids were calculated. The odds ratio (OR) of MI was estimated for the
10th percentile level of the antioxidants relative to the 90th percentile level based
on the distribution among control subjects by multiple logistic regression, with
maximum-likelihood estimation of the regression coefficients. This continuous OR
was preferred to calculating ORs in quintiles of the antioxidant distribution to avoid
irrelevant fluctuations of ORs that may occur due to small numbers when
examining interactions. The fitted model included age, center, smoking, and body
mass index (BMI) for the relation with α-tocopherol and β-carotene; the model for
selenium and MI included only age, center, and smoking. Smoking categories
included never smokers, ex-smokers, pipe/cigar smokers, and current cigarette
smokers, the last category further divided in subjects smoking fewer than 5, 6 to
10, 11 to 20, and more than 20 cigarettes per day. The significance of the
interaction of antioxidants and fatty acid composition was tested (with the
loglikelihood ratio test) by including an interaction term of the continuous,
loge-transformed variables in the logistic regression model. Subsequently, the risk
of MI of the 10th compared with the 90th percentile level of the antioxidants was
estimated at tertiles of PUFAs, MUFAs, and SFAs. Nine separate models were
required so that each combination of the three antioxidants and the three types of
fatty acids was considered.
Results
The prevalence of risk factors of coronary heart disease (CHD) among case and
control subjects is summarized in Table 1⇓. Age, serum total and HDL cholesterol,
history of hypertension, smoking, angina pectoris, diabetes mellitus, family history
for CHD, socioeconomic status, and BMI differed significantly between the two
groups. The reduced concentrations of serum cholesterol in case subjects may
reflect the cholesterol-lowering effect of the acute event.
Table 1.
Prevalence of Risk Factors for
Cardiovascular Disease Among
MI Case and Control Subjects
Mean center-adjusted values for the antioxidants and fatty acids are shown in
Table 2⇓. β-Carotene and selenium concentrations were significantly lower in case
subjects than in control subjects. Mean proportions of the SFAs myristic acid
(C14:0) and stearic acid (C18:0) were 6% and 7% lower in case subjects,
respectively; MUFAs, in particular palmitoleic acid (C16:1) and C18:1(n-7), were
higher in case subjects (both 6%), whereas PUFAs were similar for both groups.
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Fatty acid composition among subjects from different centers clearly reflected
variation in dietary intake: proportion of PUFAs varied between 11.2% in Finland
and 25.4% in Israel. The lowest proportion of MUFAs was observed in Israel (43.5%),
the highest in Spain (59.1%); Scotland had the highest SFA content (35.4%).
Table 2.
Center-Adjusted Means of
Antioxidants and Fatty Acids in
Adipose Tissue by Disease
Status
We examined the relation between antioxidant concentrations and CHD risk factors
in the control group. For β-carotene, negative associations were observed for the
number of cigarettes smoked per day (r=−.17, P<.05) and BMI (r=−.36, P<.001).
Subjects with a positive family history of CHD and those with higher socioeconomic
status had significantly higher β-carotene levels (P<.001). α-Tocopherol
concentration was also negatively associated with BMI (r=−.12, P<.001) and
number of cigarettes smoked per day (r=−.13, P=.06) and positively with
socioeconomic status (P<.05). There were no significant correlations with other risk
factors. Subjects who currently smoked cigarettes or had a negative family history
of CHD had significantly lower levels of selenium than nonsmokers (P<.001). Other
classic risk factors were not associated with selenium concentration. The
association between antioxidants and proportion of PUFAs varied among countries.
The center-adjusted partial correlation was .22 (P<.01) for α-tocopherol, .09
(P<.05) for β-carotene, and .18 (P<.01) for selenium.
To evaluate whether an association between antioxidants and MI depends on the
fatty acid composition of the adipose tissue, we tested the significance of the
interaction for each of the fatty acid categories (PUFAs, MUFAs, and SFAs) with each
antioxidant (β-carotene, α-tocopherol, and selenium). These variables were
included in a logistic regression model as continuous variables, with adjustment for
age, center, smoking, and BMI (ie, nine separate models for all possible
interactions). A significant interaction was observed for α-tocopherol and SFAs
(χ =6.68, P<.01). The interactions for β-carotene and PUFAs (χ =3.20, P=.07) and
for selenium and SFAs (χ =3.51, P=.06) were borderline significant. Subsequently,
the multivariate risk of MI at low (10th percentile value) versus high (90th percentile
value) antioxidant concentrations was calculated, both overall and for tertiles of
PUFAs, MUFAs, and SFAs (Table 3⇓). For β-carotene the association with MI
appeared to be dependent on fatty acid composition. At all levels of PUFAs an
increased risk for low β-carotene compared with high β-carotene was observed.
The highest ORs were seen at the highest PUFA level (OR for low versus high
β-carotene, 3.47; 95% confidence interval [CI], 1.93 to 6.24) and at the lowest
MUFA and SFA levels. Since PUFAs, MUFAs, and SFAs are expressed as proportions
of total fatty acids, this interrelation is to be expected. Similar calculations were
done for tertiles of the ratio between MUFAs and PUFAs (m/p ratio). The OR for MI
at low versus high β-carotene at low, medium, and high m/p ratio was 2.86 (95%
CI, 1.61 to 5.11), 2.76, and 1.38, respectively. For α-tocopherol, a significant
positive association with MI was observed at the low SFA level, and a
(nonsignificant) negative association at the high SFA level. This relation was not
reflected in the associations at different PUFA or MUFA levels. For selenium, an
inverse association with MI was seen at low PUFA (OR, 2.49; 95% CI, 1.22 to 5.09)
and high SFA (OR, 1.75; 95% CI, 0.89 to 3.42) levels.
Table 3.
Risk of Myocardial Infarction at
Low (10th Percentile) Compared
With High (90th Percentile)
Levels of Antioxidants at Different Fatty Acid Levels
The association between β-carotene and MI at different levels of PUFAs was
recomputed after excluding persons with angina pectoris; the same trend was
observed (ORs were 1.46, 2.03, and 3.20 for low, medium, and high PUFA tertiles,
respectively). To evaluate the contribution of centers with very high PUFA (Israel) or
MUFA (Spain) levels to the observed interaction between PUFA and β-carotene, ORs
were also computed that excluded these centers; this exclusion did not
considerably change the estimates (results not shown).
The association of proportion of PUFAs with risk of MI, without accounting for
antioxidant levels, was examined in a logistic regression model including tertiles of
PUFAs with adjustment for age, center, smoking, and BMI. A positive association
was observed, with an OR of 1.26 (95% CI, 0.92 to 1.71) in the middle tertile
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compared with the lowest and 1.76 (95% CI, 1.24 to 2.50) for the highest tertile.
The most important associate of MI in all multivariate models was smoking. The
ORs for the smoking categories in the model estimating coefficients for the
interaction between β-carotene and PUFAs increased from 1.72 (95% CI, 1.20 to
2.45) in ex-smokers and 1.74 (95% CI, 0.86 to 3.51) in subjects smoking fewer
than 5 cigarettes per day to 9.63 (95% CI, 6.03 to 15.4) in subjects smoking over
20 cigarettes daily compared with those who had never smoked. Smoking was also
associated with PUFA level; the mean proportion of PUFAs was 14.4% in
nonsmokers and 13.7% in smokers (P=.06). To test whether the interaction
between selenium and PUFAs was perhaps the reflection of an interaction with
smoking, we compared the fit of a no-interaction model with the fit of a model with
the selenium-PUFA interaction (both as continuous variables) and with a model that
included the selenium-smoking interaction (smoking in seven categories). The
relative improvement with the smoking interaction was larger (χ =12.30 [6 df],
P=.06) than with the PUFA interaction (χ =1.64 [1 df], P=.20). A similar approach
was used for β-carotene: improvement of the model with the β-carotene–PUFA
interaction was, as mentioned above, of borderline significance (χ =3.20, P=.07);
an interaction of β-carotene and smoking did not improve the model (χ =2.30,
P=.89).
Discussion
In this multicenter case-control study, the strongest association of low adipose
tissue β-carotene with increased risk of MI was observed when the proportion of
PUFAs in adipose tissue was high. Because a higher proportion of one type of fatty
acid implicates a lower proportion of other types, opposite results were seen for
levels of MUFAs and SFAs. Since adipose tissue levels of PUFAs best reflect dietary
intake,  levels of MUFAs and SFAs may be considered derived values that are not
directly related to intake. For α-tocopherol no association with MI was observed at
any PUFA level. An inverse association of selenium with MI was observed at low
PUFA and high SFA levels; this may be attributed to the larger proportion of
smokers in the low PUFA category.
To avoid changes in antioxidant status due to previous disease, the case subjects in
this study were those patients with acute, first-time MI. Hospital control subjects or
friends and relatives, in some of the participating centers, might not have
represented the distribution of the antioxidant status in the population from which
the case subjects had originated, although due care was taken to avoid such a bias.
If, however, a control subject’s disease was related to antioxidant status, it is most
likely to have reduced the antioxidant status and thus diminish the risk estimates
for MI. The use of friends or relatives as control subjects may lead to overmatching
on lifestyle (including diet) exposures. This would also result in a decreased
estimate of association between antioxidants and MI, thus leading to a conservative
bias. Because smoking habits and BMI were found to be confounders of the relation
between β-carotene and MI and smoking habits alone for selenium and MI, we
adjusted for these factors in the multivariate analysis. At low PUFA levels we
observed an inverse association of selenium and MI. As smoking is also associated
with PUFA status (lower PUFA levels in smokers compared with nonsmokers), the
interaction between selenium and PUFAs may also be explained by an interaction
between selenium and smoking, although we cannot say to what extent. For
β-carotene, the differential risk of MI at different proportions of PUFAs could not be
explained by an interaction with smoking. Even if there were such an interaction, it
would affect the ORs in the opposite way, as observed for selenium; better
adjustment for smoking could only enhance our findings for β-carotene and PUFAs.
The interaction between α-tocopherol and SFAs cannot easily be interpreted, since
it is not reflected in any interaction with PUFAs. Adipose tissue SFA levels by
themselves have a poor correlation with dietary fat intake.
Experimental studies indicate that the balance between antioxidant status,
oxidative stress, and PUFAs as the main substrate for oxidation may determine the
amount of damage to cells and tissues and eventually the occurrence of disease.
The oxidation of LDL is thought to be a major factor in atherogenesis, mainly by
causing an increased uptake of lipids in the macrophages in the arterial wall and by
its cytotoxic effects on endothelial cells.  Oxidation of LDL results in the formation
of hydroxylated derivatives of both oleic and linoleic acid.  However, a more
modest increase in amounts of hydroxy derivatives is seen for oleic acid compared
with linoleic acid.  Moreover, diets rich in oleic acid relative to PUFAs reduce the
uptake of LDL by macrophages.  Increasing the amount of vitamin E in the LDL
particle by oral supplementation increases the resistance to in vitro oxidation.
However, the initial concentration of vitamin E in LDL is not related to oxidation
resistance  ; this has been attributed not only to other components of LDL,
such as other antioxidants, but also to the fatty acid composition. Long-term
supplementation with β-carotene results in increased β-carotene levels in LDL, but
these enriched LDL particles are not more resistant to in vitro oxidation.  As
Reaven et al  have remarked, from the fact that β-carotene does not confer direct
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protection to LDL in in vitro experiments it should not be concluded that it has no
role as an antioxidant in the prevention of CHD. The oxidation of LDL by different
types of cells in the artery wall may well be influenced by the β-carotene content of
these cells.
We measured antioxidants in adipose tissue and toenails rather than in LDL or
plasma mainly because of the effects of recent dietary changes and the acute event
of the MI itself on plasma levels, which would severely bias the outcome of a
case-control study. When we investigated the relation between α-tocopherol and
β-carotene in adipose tissue and in plasma, we observed a correlation of .31 for
α-tocopherol and r=.62 for β-carotene (r=.77 when measurement variability was
taken into account).  The concentration of these antioxidants in adipose tissue is
also associated with dietary intake,  although perhaps not very strongly.
Inadequacies in dietary assessment methods may explain rather low correlations
with levels in adipose tissue or plasma. An important recent suggestion is that
plasma α-tocopherol levels are regulated and thus kept relatively constant.  The
resulting small variation in tissue levels would prevent finding an association with
risk of MI, at least at normal levels of intake.
Selenium in toenails, like serum selenium, has a dose-dependent relation with
selenium intake.  The fatty acid composition of adipose tissue, especially of
essential fatty acids,  is a reliable indicator of dietary intake over a longer period
of time.
There is a growing body of epidemiological evidence for an inverse relation
between antioxidant nutrients and CHD risk.  However, not all studies
have found this association.  For vitamin E, possibly only very high intake
through supplementation is associated with decreased risk of CHD.  The (mostly
preliminary) findings for β-carotene indicate an inverse association at normal
dietary intake levels.  Results of the first large preventive trial with
antioxidants  do not support these findings and even suggest that large doses of
β-carotene might be harmful. Population-based studies have scarcely addressed
the combined effect of antioxidants and dietary fatty acids on CHD risk. Kok et al
have observed lower selenium-to-PUFA ratios in cases with severe versus mild
coronary atherosclerosis, but these results were not adjusted for smoking status.
The ratio of α-tocopherol to PUFA did not differ between these groups. Riemersma
et al  report no significant interaction between adipose linoleic acid and plasma
vitamin E in the relation with angina pectoris, which agrees with our findings for
α-tocopherol. To our knowledge the interaction between β-carotene and PUFAs has
not been addressed in other studies.
In conclusion, the association of low β-carotene levels in adipose tissue with
increased risk of MI is modified by adipose tissue PUFA levels. Since adipose tissue
fatty acid composition and β-carotene concentration are reported to be indicators
of dietary intake, this finding suggests that low β-carotene intake may increase the
risk of MI in men, particularly when they consume large amounts of PUFAs. In the
evaluation of PUFA relative to MUFA and SFA levels, both the susceptibility to
oxidative stress and the cholesterol-lowering potential should be taken into
account. It is too early to make firm recommendations in favor of MUFAs over
PUFAs on the basis of available evidence. It must be stressed that the observed
association is no proof of a cause-and-effect relation; it may be possible that
β-carotene is not the protective factor, but another constituent of the diet that is
present in the same food products. In both cases, increased consumption of yellow
fruits and green leafy vegetables may improve the CHD risk profile of middle-aged
men.
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